AGTR1 and endothelial dysfunction: This was likely mediated by modulation of RAAS and prevention of AT1 receptors stimulation by Ang II that encourages the production of plaque, vasoconstriction, endothelial dysfunction, inflammation, free radicals, and smooth muscle cell hyperplasia.